Drug Type Biological products |
Synonyms- |
Target |
Mechanism CD206 modulators(Macrophage mannose receptor 1 modulators), TAM family inhibitors(Type XI RTKs: TAM (TYRO3-, AXL- and MER-TK) receptor family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 10 Oct 2021 |